Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 119,306 | 127,657 | 37,197 | 79,368 | 77,190 |
| Marketable Securities | N/A | N/A | 36,001 | N/A | N/A |
| Receivables | 232 | 4 | N/A | 34 | 10 |
| Inventories | 142 | 349 | 316 | 137 | 398 |
| TOTAL | $120,704 | $128,736 | $74,472 | $80,449 | $78,302 |
| Non-Current Assets | |||||
| PPE Net | 718 | 637 | 805 | 710 | 707 |
| Other Non-Current Assets | 80 | 29 | 273 | 29 | 29 |
| TOTAL | $798 | $666 | $1,078 | $739 | $736 |
| Total Assets | $121,502 | $129,402 | $75,550 | $81,188 | $79,038 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,655 | 4,048 | 4,435 | 3,488 | 3,543 |
| Accrued Expenses | 2,211 | 1,291 | 1,950 | 1,139 | 1,112 |
| Other current liabilities | N/A | N/A | N/A | N/A | 311 |
| TOTAL | $7,952 | $5,535 | $7,035 | $4,927 | $4,966 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 86 | 196 | 650 | 300 | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $7,952 | $5,535 | $7,035 | $4,927 | $4,966 |
| Shareholders' Equity | |||||
| Common Shares | 43 | 42 | 37 | 35 | 35 |
| Retained earnings | -78,622 | -60,596 | -47,214 | -37,128 | -36,830 |
| TOTAL | $113,550 | $123,867 | $68,515 | $76,261 | $74,072 |
| Total Liabilities And Equity | $121,502 | $129,402 | $75,550 | $81,188 | $79,038 |